Medicine and Dentistry
Programmed Death-Ligand 1
90%
Neoplasm
89%
Depletion
75%
Nodular Melanoma
72%
Immunity
70%
Ovarian Cancer
67%
Host
62%
Programmed Death 1 Ligand 1
60%
Programmed Cell Death
60%
Chlorambucil
60%
Ligand
60%
Natural Killer Cell
60%
Therapeutic Procedure
50%
CTLA-4
37%
Age
37%
Cancer Stem Cell
32%
Antibody
29%
Tumor Cell
25%
Malignant Neoplasm
24%
Cells
21%
Immunotherapy
17%
In Vitro
16%
Enalapril Maleate
15%
Adipocyte
15%
Regulatory T Cell
15%
Breast Cancer
15%
Adipose Tissue
15%
Blocking Antibody
15%
Melanoma B16
12%
Tumor Progression
11%
Autophagy
11%
Combination Therapy
10%
Cancer Immunotherapy
10%
T Cell
10%
Aptitude
9%
Immune Checkpoint Blockade
9%
Rapamycin
7%
Toxicity
7%
Anticarcinogen
7%
Equivalent Dose
7%
Denileukin Diftitox
7%
Clinical Study
7%
Pediatric Cancer
7%
Pathogenesis
7%
Treatment Response
7%
Gene Expression
5%
Interferon
5%
Gene
5%
Tumor Model
5%
Receptor
5%
Biochemistry, Genetics and Molecular Biology
PD-L1
100%
Mouse
67%
Estrogen Receptor
60%
Autophagy
60%
Host
60%
Deamination
60%
DNA
60%
Immunity
50%
Development
42%
CTLA-4
37%
Age
37%
Growth
36%
Cancer Immunotherapy
30%
Clinical Trial
25%
Antibody
22%
Cooperation
20%
Molecule
20%
Glucose Metabolism
20%
Electric Potential
20%
Phenotype
20%
Nucleic Acid Base Substitution
19%
Attention
19%
Glutamic Acid
19%
Mutant
19%
Regeneration
19%
Lysozyme
19%
Single-Stranded DNA
19%
RNA Editing
19%
Mutation
19%
Cytosine Deaminase
19%
Adipocyte
15%
Regulatory T Cell
15%
Preadipocyte
10%
Protein Degradation
8%
Tyrosine Phosphorylation
8%
Ubiquitination
8%
Cefepime
8%
Protein Content
8%
Ceftazidime
8%
T Cell Depletion
7%
Dose
7%
Preclinical Study
7%
Mouse Model
7%
Pediatrics
7%
Aptitude
7%
Pharmacokinetic Properties
7%
Cell Proliferation
7%
Interferon
5%
Gene Expression
5%
Mammalian Target of Rapamycin
5%
Immunology and Microbiology
Programmed Death-Ligand 1
60%
Cancer Immunotherapy
60%
Immune Checkpoint Blockade
60%
Programmed Death 1 Ligand 1
60%
Immunity
60%
Cells
37%
Immunocompetent Cell
25%
Breast
23%
Interferon Type I
20%
Monospecific Antibody
17%
T Cell
15%
Adipocyte
15%
Immunotherapy
15%
Myeloid
10%
CD80
10%
Cytotoxic T-Cell
10%
Adipose Tissue
10%
Immunity
10%
Protein Phosphorylation
8%
Ubiquitination
8%
Growth
8%
Tumor Cell
8%
Immunity
8%
Ligand Binding
7%
Cell Proliferation
7%
Sirolimus
5%
Gene Expression
5%
Programmed Death 1 Receptor
5%
Adipogenesis
5%
Syngenic
5%
Tissues
5%
Mouse
5%
